Kashmik Formulations Expands Operations, Eyes Global Markets and IPO

Ahmedabad | Gujarat — Established in 2017, Kashmik Formulations Pvt. Ltd. is a WHO-GMP certified pharmaceutical manufacturer, distributor, and exporter with its headquarters located in Ahmedabad. Under the leadership of its founder and Managing Director, Nilesh Patel, Kashmik Formulations has emerged into a reputed name in the Indian pharmaceutical sector known for its commitment to quality and affordability.

Antibiotics, antacids, pain relievers, and anti-allergy drugs are among its main product lines. Recently, the business entered the anti-diabetic market by launching anti-diabetic product DAPNEC (Dapagliflozin), priced up to 400% lower than those in the market.

“We aim to expand our powder-based product line, which will include essential medicines such as Oral Rehydration Salts (ORS) and antacids. These initiatives are currently in the planning and research phase, with launches expected in the near future” said Patel.

Kashmik is currently running at full capacity, making one crore tablets a day. To increase production by 50% and reach a goal of 1.5 crore tablets a day, the company is spending ₹20 crore. A significant part of its growth strategy includes increasing exports from 20% to 50% by registering products in international markets like Myanmar, Latin America, and parts of Africa and increasing domestic product range to 75+ products to meet the healthcare requirements.

Additionally, Kashmik is also investing between Rs 4-5 crore on packaging automation and AI-driven solutions to increase operational efficiency. Although it has not yet made significant investments in research partnerships, the business intends to establish a new research and development facility in Jammu. It is also planning to launch injectable medicines.

The company is thinking of doing an initial public offering (IPO) within the next two to three years as a crucial part of its strategic plan.

With ongoing investments, a knowledgeable workforce of 500+ and an international perspective, Kashmik Formulation is set to emerge as a major player in India’s healthcare and pharmaceutical export market.